Chugai Pharmaceutical Co., Ltd. (CHGCY)

Chugai Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	96,284	86,522	73,254	62,351	42,013	53,339
Market Cap Growth	37.30%	18.11%	17.49%	48.41%	-21.23%	-39.15%
Enterprise Value	89,931	80,893	67,877	57,961	37,878	49,894
Last Close Price	29.25	26.27	21.97	18.85	12.67	16.36
PE Ratio	34.78	31.26	29.74	27.00	14.80	20.27
PS Ratio	12.00	10.78	9.84	7.91	4.40	6.14
PB Ratio	7.45	6.70	6.06	5.41	3.89	5.17
P/TBV Ratio	7.66	6.88	6.11	5.47	3.96	5.27
P/FCF Ratio	48.70	43.76	29.00	26.01	30.53	28.74
P/OCF Ratio	39.08	35.12	25.73	21.44	22.70	21.96
EV/Sales Ratio	11.02	10.08	9.12	7.35	3.97	5.75
EV/EBITDA Ratio	22.27	20.57	18.60	17.35	8.85	12.69
EV/EBIT Ratio	23.50	21.49	19.69	18.60	9.37	13.62
EV/FCF Ratio	45.48	40.91	26.87	24.17	27.52	26.89
Debt / Equity Ratio	-	-	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	-	-	0.02	0.03	0.02	0.04
Debt / FCF Ratio	-	-	0.03	0.04	0.08	0.08
Asset Turnover	0.54	0.54	0.56	0.59	0.74	0.72
Inventory Turnover	1.41	1.41	1.32	1.46	1.90	1.72
Quick Ratio	3.46	3.46	4.59	3.68	2.40	2.53
Current Ratio	4.24	4.24	5.53	4.74	3.15	3.25
Return on Equity (ROE)	22.10%	22.10%	21.96%	21.34%	28.67%	27.95%
Return on Assets (ROA)	15.77%	15.77%	16.36%	14.44%	19.56%	19.01%
Return on Invested Capital (ROIC)	41.72%	43.67%	42.57%	35.09%	45.09%	45.33%
Return on Capital Employed (ROCE)	28.70%	28.70%	28.30%	26.70%	36.90%	34.80%
Earnings Yield	2.87%	3.20%	3.36%	3.70%	6.76%	4.93%
FCF Yield	2.05%	2.28%	3.45%	3.84%	3.28%	3.48%
Dividend Yield	6.15%	2.96%	2.84%	3.01%	4.67%	4.04%
Payout Ratio	68.99%	68.99%	34.40%	40.43%	36.91%	32.56%
Buyback Yield / Dilution	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%
Total Shareholder Return	6.15%	2.96%	2.83%	3.00%	4.66%	4.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.